Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study was conducted to assess the safety and efficacy of larazotide acetate versus
placebo in inducing remission in subjects with active celiac disease.